PARP1 and neoplasm: As previously shown [34,36], a rise in DNA damage was also observed in the tumors of the mice treated with rucaparib compared to the non-treated animals, suggesting that the inhibition of PARP activity elicited such a rise in damaged DNA levels within the tumor cells.